ABSTRACT
INTRODUCTION: Magnetostrictive Fe-Ga alloys have garnered extensive attention owing to their excellent magnetic properties and acceptable biocompatibility. Nevertheless, the polycrystalline Fe-Ga alloys currently available tend to display random texture orientations, which constrain their magnetostrictive performance. OBJECTIVES: To regulate the texture orientation of Fe-Ga-NbC alloys and thereby enhancing magnetostriction. METHODS: In this study, a processing route comprising laser powder bed fusion (LPBF) followed by secondary recrystallization annealing (800, 1000, and 1200 °C, respectively) was developed to prepare Fe-Ga-NbC alloys. RESULTS: The results showed that the LPBF-ed (Fe81Ga19)99(NbC)1 alloys exhibited a high content of high energy grain boundaries (HEGBs) due to the repeated melting and solidification. In subsequent annealing process, the migration of HEGBs induced the rearrangement and recrystallization of grains, during which NbC was found to locate at the grain boundaries and influence the migration path of HEGBs via selective pinning, thereby resulting in a strong Goss texture. With the rise in annealing temperature, the content of Goss texture gradually increased from the initial 3.9 % to 71.3 % at 1200 °C, leading to enhanced magnetostriction, lower saturation magnetization and coercivity. Furthermore, in alternating magnetic fields, the alloys annealed at 1200 °C also exhibited higher magnetostriction than the LPBF-ed alloys. And a noteworthy grain coarsening was also observed after annealing, accompanied by a discernible inclination of magnetic domains towards strip domains. Additional, cell tests demonstrated that the prepared alloys had satisfactory biocompatibility and the ability to promote osteogenic differentiation. CONCLUSION: These findings indicated that the LPBF-ed and annealed Fe-Ga-NbC alloys might be a promising alternative as magnetostrictive-driven materials for biomedical applications.
ABSTRACT
Introduction: Nano-SiC has attracted great attention as ceramic reinforcement in metal matrix composites, but the weak interface bonding between them remains a bottleneck for efficient strengthening. Objective: In this study, pre-oxidation treatments and selective laser melting (SLM) were employed to prepare Zn/nano-SiC biocomposites with strengthened interface bonding via in situ reaction. Methods: Nano-SiC and Zn powders were pre-oxidized respectively, and then used to prepare Zn/nano-SiC biocomposites via SLM. The powder microstructure, and the interface characteristics and mechanical properties of the biocomposites were investigated. The degradation properties and cell response were analyzed to evaluate their feasibility for orthopedic applications. Results: The results indicated that the pre-oxidation treatments generated a uniform oxide layer on the surface of both nano-SiC and Zn particles and the thickness of the oxide layer increased with pre-oxidation temperature. During the SLM process, the oxide layers not only improved the metal-ceramic wettability by reducing interface energy, but also induced in situ reaction to form chemical bonding between the Zn matrix and nano-SiC, thereby improving the interface bonding. Consequently, the Zn biocomposite reinforced by nano-SiC with a pre-oxidation temperature of 1000 °C (ZS1000 biocomposite) exhibited more transgranular fracture and significantly enhanced compressive yield strength of 171.5 MPa, which was 31.6% higher than that of the Zn biocomposite reinforced by nano-SiC without pre-oxidation. Moreover, the ZS1000 biocomposite presented slightly accelerated degradation which might be ascribed to the facilitated electron transfer by the interface product (Zn2SiO4). In addition, the ZS1000 biocomposite also showed appropriate biocompatibility for MG-63 cell adhesion, growth, and proliferation. Conclusion: This study shows the potential practical applicability for the preparation of Zn-based biocomposites with strong interface bonding and mechanical properties for orthopedic applications.
Subject(s)
Ceramics , Lasers , Oxidation-Reduction , Oxides , ZincABSTRACT
Fe-based biocomposites are emerging as temporary orthopedic implants due to natural biodegradability and high mechanical strength. Yet, the slow degradation kinetics restricts their biomedical applications. In this work, Cu-initiated redox system was established to accelerate the biodegradation of Fe-C composite scaffold prepared by selective laser melting. On the one hand, Cu induced micro-galvanic corrosion with Fe matrix due to their differences in potentials, accelerating the electron separation from Fe and further the dissolution of Fe matrix. On the other hand, Cu, as a good conductor of electron transfer, reduced the electron transfer impedance and increased the corrosion current density in Fe/C micro-galvanic cells. Consequently, the degradation rate of Fe-C scaffold was increased by 69% from 0.16 mm/y to 0.27 mm/y in the immersion tests. Additionally, the composite scaffold exhibited compression strength of 128 MPa and hardness of 148 HV, respectively. After co-culturing with the composite scaffold, MG-63 cells presented classical fusiform shape and good cell viability, indicating favorable biocompatibility. These results showed the potential applications of the developed redox systems as highly efficient initiator in accelerating the biodegradation of Fe-based biocomposites.
Subject(s)
Alloys , Biocompatible Materials , Alloys/pharmacology , Biocompatible Materials/pharmacology , Corrosion , Materials Testing , Oxidation-ReductionABSTRACT
Magnetostrictive alloys have attracted increasing attention in biomedical applications because of the ability to generate reversible deformation in the presence of external magnetic fields. This review focuses on the advances in magnetostrictive alloys and their biomedical applications. The theories of magnetostriction are systematically summarized. The different types of magnetostrictive alloys and their preparation methods are also reviewed in detail. The magnetostrictive strains and phase compositions of typical magnetostrictive alloys, including iron based, rare-earth based and ferrite materials, are presented. Besides, a variety of approaches to preparing rods, blocks and films of magnetostriction materials, as well as the corresponding methods and setups for magnetostriction measurement, are summarized and discussed. Moreover, the interactions between magnetostrictive alloys and cells are analyzed and emphasis is placed on the transduction and transformation process of mechanochemical signals induced by magnetostriction. The latest applications of magnetostrictive alloys in remote microactuators, magnetic field sensors, wireless implantable devices and biodegradable implants are also reviewed. Furthermore, future research directions of magnetostrictive alloys are prospected with focus on their potential applications in remote cell actuation and bone repair.
ABSTRACT
In the present study, an antibacterial biomedical magnesium (Mg) alloy with a low biodegradation rate was designed, and ZK30-0.2Cu-xMn (x = 0, 0.4, 0.8, 1.2, and 1.6 wt%) was produced by selective laser melting, which is a widely applied laser powder bed fusion additive manufacturing technology. Alloying with Mn evidently influenced the grain size, hardness, and biodegradation behavior. On the other hand, increasing Mn content to 0.8 wt% resulted in a decrease of biodegradation rate which is attributed to the decreased grain size and relatively protective surface layer of manganese oxide. Higher Mn contents increased the biodegradation rate attributed to the presence of the Mn-rich particles. Taken together, ZK30-0.2Cu-0.8Mn exhibited the lowest biodegradation rate, strong antibacterial performance, and good cytocompatibility.
ABSTRACT
Bone defects caused by tumors are difficult to repair clinically because of their poor morphology and residual tumor cell-induced recurrence. Scaffolds with the dual function of bone repair and bone tumor treatment are urgently needed to resolve this problem. In this study, a poly(L-lactic acid) (PLLA)/nanoscale hydroxyapatite (nHA)/metformin (MET) nanocomposite scaffold was constructed via selective laser sintering. The scaffolds were expected to combine the excellent mechanical strength and biodegradability of PLLA, the good bioactivity of nHA, and the water solubility and antitumor properties of MET. The PLLA/nHA/MET scaffolds showed improved cell adhesion, appropriate porosity, good biocompatibility and osteogenic-induced ability in vitro because metformin improves water solubility and promotes the osteogenic differentiation of cells within the scaffold. The PLLA/nHA/MET scaffold had an extended drug release time because the MET particles were wrapped in the biodegradable polymer PLLA and the wrapped MET particles were slowly released into body fluids as the PLLA was degraded. Moreover, the scaffold induced osteosarcoma (OS) cell apoptosis by upregulating apoptosis-related gene expression and showed excellent tumor inhibition characteristics in vitro. In addition, the scaffold induced osteogenic differentiation of bone marrow mesenchymal cells (BMSCs) by promoting osteogenic gene expression. The results suggest that the PLLA/nHA/MET composite scaffold has the dual function of tumor inhibition and bone repair and therefore it provides a promising new approach for the treatment of tumor-induced bone defects.
Subject(s)
Bone Neoplasms , Metformin , Bone Neoplasms/drug therapy , Durapatite , Humans , Lactic Acid , Metformin/pharmacology , Osteogenesis , Polyesters , Tissue Engineering , Tissue ScaffoldsABSTRACT
Hydroxyapatite (HAP) can endow a biopolymer scaffold with good bioactivity and osteoconductive ability, while the interfacial bonding is fairly weak between HAP and biopolymers. In this study, HAP was in situ generated on poly(l-lactic acid) (PLLA) particles, and then they were used to fabricate a scaffold by selective laser sintering. Detailedly, PLLA particles were first functionalized by dopamine oxide polymerization, which introduced abundance active catechol groups on the particle surface, and subsequently, the catechol groups concentrated Ca2+ ions by chelation in a simulated body fluid solution, and then, Ca2+ ions absorbed PO43- ions through electrostatic interactions for in situ nucleation of HAP. The results indicated that HAP was homogeneously generated on the PLLA particle surface, and HAP and PLLA exhibited good interfacial bonding in the HAP/PLLA scaffolds. Meanwhile, the scaffolds displayed excellent bioactivity by inducing apatite precipitation and provided a good environment for human bone mesenchymal stem cell attachment, proliferation, and osteogenic differentiation. More importantly, the ingrowth of blood vessel and the formation of new bone could be stimulated by the scaffolds in vivo, and the bone volume fraction and bone mineral density increased by 44.44 and 41.73% compared with the pure PLLA scaffolds, respectively. Serum biochemical indexes fell within the normal range, which indicated that there was no harmful effect on the normal functioning of the body after implanting the scaffold.
Subject(s)
Durapatite/chemistry , Mesenchymal Stem Cells/cytology , Polyesters/chemistry , Tissue Scaffolds/chemistry , Bone Density , Bone Regeneration , Durapatite/chemical synthesis , Humans , Molecular Structure , Osteogenesis , Particle Size , Surface Properties , Tissue EngineeringABSTRACT
Fe is regarded as a promising bone implant material due to inherent degradability and high mechanical strength, but its degradation rate is too slow to match the healing rate of bone. In this work, hydrolytic expansion was cleverly exploited to accelerate Fe degradation. Concretely, hydrolyzable Mg2Si was incorporated into Fe matrix through selective laser melting and readily hydrolyzed in a physiological environment, thereby exposing more surface area of Fe matrix to the solution. Moreover, the gaseous hydrolytic products of Mg2Si acted as an expanding agent and cracked the dense degradation product layers of Fe matrix, which offered rapid access for solution invasion and corrosion propagation toward the interior of Fe matrix. This resulted in the breakdown of protective degradation product layers and even the direct peeling off of Fe matrix. Consequently, the degradation rate for Fe/Mg2Si composites (0.33 mm/y) was significantly improved in comparison with that of Fe (0.12 mm/y). Meanwhile, Fe/Mg2Si composites were found to enable the growth and proliferation of MG-63 cells, showing good cytocompatibility. This study indicated that hydrolytic expansion may be an effective strategy to accelerate the degradation of Fe-based implants.
ABSTRACT
The combination of biopolymer and bioceramic can mimic the chemical composition of the native bone extracellular matrix which is composed of inorganic minerals and organic collagenous. However, the poor interfacial compatibility between organic biopolymer and inorganic bioceramic restricts the full development of bioceramic/biopolymer composite scaffold for bone regeneration application. Coupling agents have been widely used to build a "molecular bridge" in the interface between biopolymer and bioceramic due to the two different functional groups in its structure. One is organophilic functional groups which can react with polymer molecules, and the other is special functional groups which can adsorb on bioceramic surface to form a firm bond. As a result, the stress transfer efficiency between biopolymer and bioceramic can be enhanced, and thereby improving the mechanical properties of the composite scaffold. In this study, the interfacial features between bioceramic and biopolymer and the methods to improve interface bonding were presented, and the interfacial reaction mechanisms under the action of coupling agents especially silane coupling agents were focused on discussing. In addition, the mechanical properties, in vitro and in vivo biological properties of the bioceramic/biopolymer composite scaffold after coupling agent modification were systematically summarized. Finally, suggestions for further work were put forward, including the study on controlling coupling agent content, and more in vitro and in vivo experimental evaluation.
Subject(s)
Biocompatible Materials/chemistry , Biopolymers/chemistry , Bone Regeneration , Bone and Bones/chemistry , Extracellular Matrix/chemistry , Materials Testing , Particle Size , Surface PropertiesABSTRACT
Graphene oxide (GO) can improve the degradation resistance of biomedical Mg alloy because of its excellent impermeability and outstanding chemical inertness. However, the weak interfacial bonding between GO and Mg matrix leads to easily detaching during degradation. In this study, in situ reaction induced by TiO2 took place in the AZ61-GO biocomposite to enhance the interfacial bonding between GO and Mg matrix. For the specific process, TiO2 was uniformly and tightly deposited onto the GO surface by hydrothermal reaction (TiO2/GO) first and then used for fabricating AZ61-TiO2/GO biocomposites by selective laser melting (SLM). Results showed that TiO2 was in situ reduced by magnesiothermic reaction during SLM process, and the reduzate Ti, on the one hand, reacted with Al in the AZ61 matrix to form TiAl2 and, on the other hand, reacted with GO to form TiC at the AZ61-GO interface. Owing to the enhanced interfacial bonding, the AZ61-TiO2/GO biocomposite showed 12.5% decrease in degradation rate and 10.1% increase in compressive strength as compared with the AZ61-GO biocomposite. Moreover, the AZ61-TiO2/GO biocomposite also showed good cytocompatibility because of the slowed degradation. These findings may provide guidance for the interfacial enhancement in GO/metal composites for biomedical applications.
Subject(s)
Alloys/chemistry , Coated Materials, Biocompatible/chemistry , Graphite/chemistry , Titanium/chemistry , Alloys/toxicity , Cell Line, Tumor , Coated Materials, Biocompatible/toxicity , Graphite/toxicity , Humans , Magnesium/chemistry , Magnesium/toxicity , Titanium/toxicityABSTRACT
Magnesium-based biomaterials are attracting increasingly more attention for orthopedic applications based on their appropriate mechanical properties, biodegradability, and favorable biocompatibility. However, the high corrosion rate of these materials remains to be addressed. In this study, porous ß-Ca3(PO4)2/Mg-Zn (ß-TCP/Mg-Zn) composites were fabricated via a powder metallurgy method. The ß-TCP/Mg-Zn composites with 6% porosity exhibited optimal mechanical properties, and thus, they were selected for surface modification. A novel dopamine/gelatin/recombinant human bone morphogenetic protein-2 (rhBMP-2) coating with demonstrated stability was prepared to further improve the corrosion resistance of the composite and enhance early osteoinductivity. The homogeneously coated ß-TCP/Mg-Zn composite showed significantly improved corrosion resistance according to electrochemical and immersion tests. In addition, extracts from the dopamine/gelatin/rhBMP-2-coated ß-TCP/Mg-Zn composite not only facilitated cell proliferation but also significantly enhanced the osteogenic differentiation of Sprague-Dawley rat bone marrow-derived mesenchymal stem cells in vitro. Furthermore, in vivo experiments were performed to evaluate the biodegradation, histocompatibility, and osteoinductive potential of the coated composite. No obvious pathological changes in the vital visceral organs were observed after implantation, and radiography and hematoxylin-eosin staining showed strong promotion of new bone formation, matched composite degradation and bone regeneration rates, and complete absorption of the released hydrogen gas. Collectively, these results indicate that the dopamine/gelatin/rhBMP-2-coated ß-TCP/Mg-Zn composite offers improved corrosion resistance, favorable biocompatibility, and enhanced osteoinductive potential for use in the fabrication of orthopedic implants.
Subject(s)
Bone and Bones , Coated Materials, Biocompatible/chemistry , Coated Materials, Biocompatible/pharmacology , Materials Testing , Prostheses and Implants , Animals , Bone Morphogenetic Protein 2 , Calcium Phosphates , Dopamine , Female , Gelatin , Magnesium , Male , Mesenchymal Stem Cells , Rabbits , Rats , ZincABSTRACT
Zn alloy is recognized as a promising biodegradable metal for bone implant applications because of its good biocompatibility and moderate degradation rate. Nevertheless, the insufficient strength limits its applications. In this study, a rod-like eutectic structure was fabricated in Zn-Al-Sn alloy with the addition of Sn via selective laser melting. It was found that the Al-enriched phase nucleated primarily during cooling and caused the rapid precipitation of Zn. This inevitably consumed the liquid Zn and increased the ratio of Sn to Zn in the liquid phase, resulting in the formation of the eutectic, which was composed of the Sn-enriched phase and the Zn-enriched phase. More importantly, the coupled growth of the Sn-enriched and Zn-enriched phases and their volume differences together led to a rod-like morphology of the eutectic according to the volume fraction theory. Consequently, the yield and ultimate compressive strengths were enhanced to 180 ± 18.8 and 325 ± 29.6 MPa for the Zn-Al-2Sn alloy, respectively. This could be attributed to the pinning effect of the rod-like eutectic, which could block dislocation motion and result in dislocation pile-up, thereby conducing to the mechanical reinforcement. In addition, the Zn-Al-Sn alloy also exhibited good biocompatibility and increased degradation rate because of the enhanced galvanic corrosion. This study showed the potential of rod-like eutectic for the mechanical enhancement of the biodegradable Zn alloy.
Subject(s)
Absorbable Implants , Alloys , Corrosion , Materials Testing , ZincABSTRACT
The slow degradation of Fe severely restricts its application in bone repair although it possesses good biocompatibility and high mechanical properties. In this study, carbon nanotubes (CNTs) were introduced to accelerate Fe biodegradation: (I) CNTs acted as cathodes to induce galvanic corrosion owing to their differences in corrosion potential; (II) The large specific surface area of CNTs increased area ratios of cathode to anode; (III) The excellent electrical conductivity of CNTs allowed significant levels of electron transfer through the cathode in galvanic corrosion. Consequently, the degradation rate of Fe/CNTs composites greatly increased by 74% with the increase of CNTs (0.3-0.9â¯wt%). Further addition of CNTs would lead to corrosion holes and cracks due to localized corrosion. Besides, cell culture experiments showed that MG-63 cells could normally proliferate to maintain their population, indicating good cytocompatibility of Fe/CNTs composites. The results proved that the incorporation of CNTs into Fe was an effective approach to develop Fe-based bone implants with enhanced degradation rates.
Subject(s)
Iron/chemistry , Nanotubes, Carbon/chemistry , Biodegradation, Environmental , Cell Line, Tumor , Cell Survival , Corrosion , Electrochemistry , Hardness , Humans , Nanotubes, Carbon/ultrastructure , Particle Size , X-Ray DiffractionABSTRACT
Iron (Fe) has been highly anticipated as a bone implant material owing to the biodegradability and excellent mechanical properties, but limited by the slow degradation and poor bioactivity. In this study, novel Fe-palladium (Pd)-bredigite biocomposites were developed by selective laser melting aiming to improve both the degradation behavior and bioactivity of Fe. The results showed that most Pd formed Pd-rich intermetallic phases (IMPs) with a nearly continuous network while the bredigite phase was distributed at the grain boundaries. In addition, a large amount of much nobler IMPs formed micro-galvanic pairs with the Fe matrix, inducing tremendous micro-galvanic corrosion. The IMPs contained a high amount of Pd2+ with a high reduction potential, which further promoted the efficiency of micro-galvanic corrosion. Moreover, the rapid degradation of bredigite also facilitated the penetration of the corrosion medium. As a result, the Fe-4Pd-5bredigite biocomposite showed a uniform degradation with a rate that is 6 times that of Fe. Furthermore, the developed Fe-Pd-bredigite biocomposites also featured excellent bioactivity, cytocompatibility, and suitable mechanical properties as characterized by the rapid apatite deposition, normal proliferation of human osteoblast-like cells (MG-63), and comparable strength and microhardness with the native bone. Overall, this study opens a new avenue for improving both the degradation and bioactivity of Fe-based composites and may facilitate their applications as biodegradable implants for tissue/organ repair.
ABSTRACT
It is difficult for a single component biopolymer to meet the requirements of scaffold at present. The development of multicomponent biopolymer based scaffold provides an effective method to solve the issue based on the advantages of each kind of the biomaterials. However, the compatibility between different components might be very poor due to the difficulties in forming strong interfacial bonding, and thereby significantly degrading the integrated mechanical properties of the scaffold. In recent years, interface phase introduction, surface modification and in situ growth have been the major strategies for enhancing interfacial bonding. This article presents a comprehensive overview on the research in the area of constructing multicomponent biopolymer based scaffold and reinforcing their interfacial properties, and more importantly, the interfacial bonding mechanisms are systematically summarized. Detailly, interface phase introduction can build a bridge between biopolymer and other components to form strong interface bonding with the two phases under the action of interface phase. Surface modification can graft organic molecules or polymers containing functional groups onto other components to crosslink with biopolymer. In situ growth can directly in situ synthesize other components with the action of nucleating agent serving as an adherent platform for the nucleation and growth of other components to biopolymer surface by chemical bonding. In addition, the mechanical properties (including strength and modulus) and biological properties (including bioactivity, cytocompatibility and biosensing in vitro, and tissue compatibility, bone regeneration capacity in vivo) of multicomponent biopolymer based scaffold after interfacial reinforcing are also reviewed and discussed. Finally, suggestions for further research are given with highlighting the need for specific investigations to assess the interface formation, structure, properties, and more in vivo studies of scaffold before applications.
Subject(s)
Biopolymers/chemistry , Tissue Scaffolds/chemistry , Biocompatible Materials/chemistry , Materials Testing , Surface Properties , Tensile StrengthABSTRACT
Additive manufacturing (AM) can obtain not only customized external shape but also porous internal structure for scaffolds, both of which are of great importance for repairing large segmental bone defects. The scaffold fabrication process generally involves scaffold design, AM, and post-treatments. Thus, this article firstly reviews the state-of-the-art of scaffold design, including computer-aided design, reverse modeling, topology optimization, and mathematical modeling. In addition, the current characteristics of several typical AM techniques, including selective laser sintering, fused deposition modeling (FDM), and electron beam melting (EBM), especially their advantages and limitations are presented. In particular, selective laser sintering is able to obtain scaffolds with nanoscale grains, due to its high heating rate and a short holding time. However, this character usually results in insufficient densification. FDM can fabricate scaffolds with a relative high accuracy of pore structure but with a relative low mechanical strength. EBM with a high beam-material coupling efficiency can process high melting point metals, but it exhibits a low-resolution and poor surface quality. Furthermore, the common post-treatments, with main focus on heat and surface treatments, which are applied to improve the comprehensive performance are also discussed. Finally, this review also discusses the future directions for AM scaffolds for bone tissue engineering.
ABSTRACT
Mg alloys degrade rather rapidly in a physiological environment, although they have good biocompatibility and favorable mechanical properties. In this study, Ti was introduced into AZ61 alloy fabricated by selective laser melting, aiming to improve the corrosion resistance. Results indicated that Ti promoted the formation of Al-enriched eutectic α phase and reduced the formation of ß-Mg17Al12 phase. With Ti content reaching to 0.5 wt.%, the Al-enriched eutectic α phase constructed a continuous net-like structure along the grain boundaries, which could act as a barrier to prevent the Mg matrix from corrosion progression. On the other hand, the Al-enriched eutectic α phase was less cathodic than ß-Mg17Al12 phase in AZ61, thus alleviating the corrosion progress due to the decreased potential difference. As a consequence, the degradation rate dramatically decreased from 0.74 to 0.24 mg·cm-2·d-1. Meanwhile, the compressive strength and microhardness were increased by 59.4% and 15.6%, respectively. Moreover, the Ti-contained AZ61 alloy exhibited improved cytocompatibility. It was suggested that Ti-contained AZ61 alloy was a promising material for bone implants application.
ABSTRACT
Bone implants are expected to possess antibacterial ability and favorable biodegradability. Ag possesses broad-spectrum antibacterial effects through destroying the respiration and substance transport of bacteria. In this study, Ag was introduced into Mg-3Zn-0.5Zr (ZK30) via selective laser melting technology. Results showed that ZK30-Ag exhibited a strong and stable antibacterial activity against the bacterium Escherichia coli. Moreover, the degradation resistance was enhanced due to the comprehensive effect of positive shifted corrosion potential (from -1.64 to -1.53 V) and grains refinement. The positive shifted corrosion potential reduced the severe galvanic corrosion by lowering the corrosion potential difference between the matrix and the second phase. Meanwhile, the introduction of Ag caused the grain refinement strengthening and precipitated-phase strengthening, resulting in improved compressive yield strength and hardness. Furthermore, ZK30-0.5Ag exhibited good biocompatibility. It was suggested that Ag-modified ZK30 was potential candidate for bone implants.
Subject(s)
Anti-Bacterial Agents , Biocompatible Materials , Prostheses and Implants , Silver , Alloys , Bone and Bones , Compressive Strength , Corrosion , Escherichia coli , Hardness , Materials TestingABSTRACT
Polyetheretherketone (PEEK)/ß-tricalcium phosphate (ß-TCP) scaffolds are expected to be able to combine the excellent mechanical strength of PEEK and the good bioactivity and biodegradability of ß-TCP. While PEEK acts as a closed membrane in which ß-TCP is completely wrapped after the melting/solidifying processing, the PEEK membrane degrades very little, hence the scaffolds cannot display bioactivity and biodegradability. The strategy reported here is to blend a biodegradable polymer with PEEK and ß-TCP to fabricate multi-material scaffolds via selective laser sintering (SLS). The biodegradable polymer first degrades and leaves caverns on the closed membrane, and then the wrapped ß-TCP is exposed to body fluid. In this study, poly(l-lactide) (PLLA) is adopted as the biodegradable polymer. The results show that large numbers of caverns form on the membrane with the degradation of PLLA, enabling direct contact between ß-TCP and body fluid, and allowing for their ion-exchange. As a consequence, the scaffolds display the bioactivity, biodegradability and cytocompatibility. Moreover, bone defect repair studies reveal that new bone tissues grow from the margin towards the center of the scaffolds from the histological analysis. The bone defect region is completely connected to the host bone end after 8 weeks of implantation.
ABSTRACT
The orthopedic application of Zn is limited owing to the poor strength and low plasticity. In this study, a novel strategy by combining rapid solidification obtained by selective laser melting (SLM) and alloying with Mg was proposed to improve the mechanical properties of Zn. The microstructures, mechanical properties, as well as in vitro cytocompatibility of SLM processed Zn-xMg (xâ¯=â¯0-4â¯wt%) were studied systematically. Results shown that SLM processed Zn-xMg alloys consisted of fine equiaxed α-Zn grains with homogeneously precipitated Mg2Zn11 along grain boundaries. More importantly, the grains size of α-Zn was decreased from 104.4⯱â¯30.4⯵m to 4.9⯱â¯1.4⯵m with Mg increasing. And Mg mainly dissolved in α-Zn developing into supersaturated solid solution due to rapid solidification effect. As a consequence, the ultimate tensile strength and elongation were enhanced by 361% and 423%, respectively, with Mg containing up to 3â¯wt%. Meanwhile, alloying with Mg enhanced the corrosion resistance of Zn, with the degradation rate decreasing from 0.18⯱â¯0.03â¯mmâ¯year-1 to 0.10⯱â¯0.04â¯mmâ¯year-1. Furthermore, SLM processed Zn-xMg exhibited good biocompatibility. This research suggested that SLM processed Zn-3Mg alloy was a potential biomaterial for orthopedic applications.